[
    [
        {
            "time": "2021-04-27",
            "original_text": "云南白药一季度净利润同比下降40%的背后是因为炒股“失利”！盈利能力下降",
            "features": {
                "keywords": [
                    "云南白药",
                    "一季度",
                    "净利润",
                    "同比下降",
                    "炒股",
                    "失利",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "云南白药一季度净利润同比下降40%的背后是因为炒股“失利”！盈利能力下降",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-04-27",
            "original_text": "晚间公告丨4月27日这些公告有看头",
            "features": {
                "keywords": [
                    "晚间公告",
                    "4月27日"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "晚间公告丨4月27日这些公告有看头",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 3,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-27",
            "original_text": "云南白药一季度增收不增利 基本每股收益下降40% 盈利能力下降",
            "features": {
                "keywords": [
                    "云南白药",
                    "一季度",
                    "增收不增利",
                    "每股收益",
                    "下降40%",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "云南白药一季度增收不增利 基本每股收益下降40% 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-04-27",
            "original_text": "云南白药(000538.SZ)第一季度归母净利润同比下降40.48%至7.63亿元 盈利能力下降",
            "features": {
                "keywords": [
                    "云南白药",
                    "第一季度",
                    "归母净利润",
                    "同比下降",
                    "40.48%",
                    "7.63亿元",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "云南白药(000538.SZ)第一季度归母净利润同比下降40.48%至7.63亿元 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-27",
            "original_text": "云南白药：2021年第一季度净利润约7.63亿元，同比下降40.48% 盈利能力下降",
            "features": {
                "keywords": [
                    "云南白药",
                    "2021年第一季度",
                    "净利润",
                    "7.63亿元",
                    "同比下降",
                    "40.48%",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "云南白药：2021年第一季度净利润约7.63亿元，同比下降40.48% 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-04-27",
            "original_text": "云南白药(000538.SZ)一季度扣非净利润升29.42%至13.65亿元",
            "features": {
                "keywords": [
                    "云南白药",
                    "一季度",
                    "扣非净利润",
                    "升29.42%",
                    "13.65亿元"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "云南白药(000538.SZ)一季度扣非净利润升29.42%至13.65亿元",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-04-27",
            "original_text": "云南白药：一季度净利润7.63亿元，同比下降40.48% 盈利能力下降",
            "features": {
                "keywords": [
                    "云南白药",
                    "一季度",
                    "净利润",
                    "7.63亿元",
                    "同比下降",
                    "40.48%",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "云南白药：一季度净利润7.63亿元，同比下降40.48% 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-07-30",
            "original_text": "电鳗快报|云南白药拟控股港股公司布局工业大麻全产业链 7月30日前“定乾坤”",
            "features": {
                "keywords": [
                    "云南白药",
                    "控股",
                    "港股公司",
                    "工业大麻",
                    "全产业链",
                    "7月30日"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "工业大麻"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "电鳗快报|云南白药拟控股港股公司布局工业大麻全产业链 7月30日前“定乾坤”",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]